confirms

Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, including redosed healthy volunteers Study results support the chronic …

Researchers at the University of Chicago have developed a comprehensive mathematical model that predicts diabetes complications up to 15 years in advance, offering clinicians a powerful new tool to understand …

Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2 diabetes, with one clinically balanced definition linking drug use to reduced cardiovascular …